Versiti, Blood Research Institute, Milwaukee, Wisconsin, USA.
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Transfusion. 2021 Apr;61(4):1278-1285. doi: 10.1111/trf.16275. Epub 2021 Jan 22.
We previously described a mouse model in which platelet immunization between selected strains leads to production of alloantibodies and severe autoimmune thrombocytopenia and mimics the human condition posttransfusion purpura (PTP). This report describes studies defining epitopes recognized by these alloantibodies.
Hybridomas were produced from spleen cells of immunized mice. Glycoprotein (GP) targets of resulting monoclonal antibodies were characterized by immunoprecipitation using platelets from the immunizing strains. Antigens defined by single amino acid (AA) polymorphisms recognized by monoclonal antibodies were identified by mutagenizing target glycoproteins expressed in Chinese hamster ovary cells and observing the effects on antibody binding.
Three monoclonal antibodies (417.1, 417.3, 425.1) were produced that recognized GPIIb on immunizing platelets. Monoclonal antibodies 417.1 and 417.3 both required G111 and 425.1 required V37, located on the beta propeller domain of GPIIb, for binding to platelets from the immunizing strains C57 and PWK, respectively. Injection of 417.3 and 425.1 into mice caused platelet destruction only in mice with GPIIb containing the targeted AAs.
Findings made provide evidence that alloantibodies produced by mice experiencing thrombocytopenia in a mouse model of PTP are specific for single AA polymorphisms that differ in GPIIb/IIIa integrin of the immunizing and immunized strains and therefore closely resemble the potent alloantibodies found in patients with PTP. The observations show that naturally occurring single AA differences in GPIIb/IIIa integrin of various mouse strains are highly immunogenic in the mouse strains studied and readily induce antibodies comparable to human platelet antigen-specific antibodies found in transfused and pregnant humans.
我们之前描述了一种小鼠模型,其中选择的品系之间的血小板免疫会导致产生同种抗体和严重的自身免疫性血小板减少症,并模拟了人类输血后紫癜(PTP)后的情况。本报告描述了定义这些同种抗体所识别表位的研究。
从免疫小鼠的脾细胞中产生杂交瘤。使用来自免疫品系的血小板通过免疫沉淀来鉴定产生的单克隆抗体的糖蛋白(GP)靶标。通过突变在中华仓鼠卵巢细胞中表达的靶糖蛋白,并观察对抗体结合的影响,鉴定由单氨基酸(AA)多态性识别的单克隆抗体所定义的抗原。
产生了三种单克隆抗体(417.1、417.3、425.1),它们识别免疫血小板上的 GPIIb。单克隆抗体 417.1 和 417.3 均需要 G111,而 425.1 分别需要位于 GPIIbβ 三叶桨域的 V37,才能与免疫品系 C57 和 PWK 的血小板结合。将 417.3 和 425.1 注射到小鼠中,仅在含有靶向 AA 的 GPIIb 的小鼠中引起血小板破坏。
这些发现提供了证据,表明在 PTP 的小鼠模型中经历血小板减少症的小鼠产生的同种抗体是针对免疫和免疫品系的 GPIIb/IIIa 整合素中单个 AA 多态性特异的,因此与 PTP 患者中发现的强效同种抗体非常相似。这些观察结果表明,各种小鼠品系中 GPIIb/IIIa 整合素中天然存在的单个 AA 差异在研究的小鼠品系中具有高度免疫原性,并且容易诱导与在输注和妊娠人群中发现的人类血小板抗原特异性抗体相当的抗体。